Phase II Trial of Antibody Treatment for Mild Asthma Shows Positive Outcomes
Researchers from McMaster University claim to have successfully examined an antibody that reduces inflammation in the lungs of asthma sufferers.
Read more
Clinical Research Society
International Society for Clinical Research and Translational Medicine